Bio Medica Laboratories IPO Details
The Bio Medica Laboratories IPO is a book build issue with a total issue size of ₹52 cr, comprising of fresh issue of 3206000 equity shares., and a offer for sale of 377000 equity shares. Bio Medica Laboratories IPO opened for subscription on May 21, 2026 and closed on May 25, 2026. Bio Medica Laboratories IPO is set price band at ₹132 to ₹139 per share, with a lot size of 1000 shares. Minimum investment for Retail investors was ₹278,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on May 26, 2026, and listed on the NSE on May 29, 2026.
Skyline Financial Services Private Ltd has been appointed as the registrar. Narnolia Financial Services are the Book Running Lead Manager for the issue.
Before investing in the Bio Medica Laboratories IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 132 – 139
- Lot Size
- 1000
- Issue Size
- ₹52 Cr
- Minimum Investment
- ₹278000 (2000 Shares)
- Listing Date
- 29 May 2026
Current GMP
₹0 (0.00%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Bio Medica Laboratories Limited
Bio Medica Laboratories is engaged in the manufacturing of pharmaceutical parenteral formulations, offering a diverse portfolio of ethical drugs, generic medicines, and over-the-counter (OTC) products. The company specializes in the production of liquid and dry powder injectables available in both single-dose and multi-dose formats, catering to the requirements of human as well as veterinary healthcare sectors.
Product Portfolio
- Liquid Injectables: 58 products
- Dry Powder Injectables: 15 products
The company provides a comprehensive range of pharmaceutical products, including:
- Generic drugs
- Branded pharmaceuticals
- OTC medications
- Other injectable formulations
Business Model
Bio Medica Laboratories operates primarily on a Business-to-Business (B2B) contract manufacturing model. The company develops and manufactures formulations for various pharmaceutical companies based on their specific requirements, product specifications, and quality standards.
Certifications & Compliance
The company adheres to stringent quality and regulatory standards and has been awarded:
- Good Manufacturing Practices (GMP) Certification
- Good Laboratory Practices (GLP) Certification
These certifications have been issued by the Food & Drugs Administration, Madhya Pradesh.
Manufacturing Facilities
Bio Medica Laboratories operates two manufacturing facilities located in Indore, equipped to support the production of high-quality injectable pharmaceutical formulations.
Bio Medica Laboratories IPO Promoters
- Mukesh Mehta
- Pradeep Mehta
Promoters Holding
Holding Pre Issue
99.99%
Holding Post Issue
0.00%
Bio Medica Laboratories IPO Objective
The Company Bio Medica Laboratories IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Repayment of Loan
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- General Corporate Purposes
Address / Contact Info
Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/
IPO Snapshot
Book Running Lead Managers
- Narnolia Financial Services
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Bio Medica Laboratories IPO is a Book-building IPO with a total issue size of ₹52 crore. The Bio Medica Laboratories IPO price band is ₹132 to 139 per share. The Bio Medica Laboratories IPO subscription opens on Thu, May 21, 2026, and closes on Mon, May 25, 2026. The Bio Medica Laboratories IPO will be listed on the NSE. Skyline Financial Services Private Ltd is the registrar for the Bio Medica Laboratories IPO.
The Bio Medica Laboratories IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026
Bio Medica Laboratories IPO Price Band is ₹132 to 139 per share.
Bio Medica Laboratories IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹278000 based on the upper price band
The minimum investment for Bio Medica Laboratories IPO is ₹278000, based on one lot of 1000 shares at the upper price band of ₹139 per share.
Investors can apply for the Bio Medica Laboratories IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, May 25, 2026. The application amount remains blocked until the Bio Medica Laboratories IPO allotment is finalized.
Bio Medica Laboratories IPO issue size is ₹52 crores.
Bio Medica Laboratories IPO allotment date is Wed, Jul 1, 2026.
The registrar for Bio Medica Laboratories IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website to check Bio Medica Laboratories IPO allotment status, refund processing, and other IPO-related information.